1 |
Park M, Hur M, Kim H, Lee CH, Lee JH, Kim HW, Nam M, Lee S. Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients. Diagnostics (Basel) 2023;13. [PMID: 36673069 DOI: 10.3390/diagnostics13020259] [Reference Citation Analysis]
|
2 |
Mesquita JR. Molecular Advances in SARS-CoV-2: A Brief Update on Transmission, Infection, and Pathology Aspects. Int J Mol Sci 2022;23. [PMID: 36430725 DOI: 10.3390/ijms232214250] [Reference Citation Analysis]
|
3 |
Sun Y, Zou Y, Wang H, Cui G, Yu Z, Ren Z. Immune response induced by novel coronavirus infection. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.988604] [Reference Citation Analysis]
|
4 |
Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC. Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. Ann Clin Transl Neurol 2022. [PMID: 36204816 DOI: 10.1002/acn3.51631] [Reference Citation Analysis]
|
5 |
Shen JK, Zhang HT. Function and structure of bradykinin receptor 2 for drug discovery. Acta Pharmacol Sin 2022. [PMID: 36075965 DOI: 10.1038/s41401-022-00982-8] [Reference Citation Analysis]
|
6 |
Szukiewicz D, Wojdasiewicz P, Watroba M, Szewczyk G, Xu B. Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence. Journal of Immunology Research 2022;2022:1-22. [DOI: 10.1155/2022/9534163] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
7 |
Ansotegui IJ, Bernstein JA, Canonica GW, Gonzalez-Diaz SN, Martin BL, Morais-Almeida M, Murrieta-Aguttes M, Sanchez Borges M. Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride. Allergy Asthma Clin Immunol 2022;18:41. [PMID: 35562767 DOI: 10.1186/s13223-022-00677-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|